MIAT expression correlates with disease aggressiveness, and is directly regulated by oct4. MIAT upregulation supports monoclonal malignant B cell proliferation with naïve B-cell phenotype by protecting from apoptosis, and thus, contributing to CLL progression [21]. The gene discussed is MIAT; the disease is B-cell chronic lymphocytic leukemia.